Sex Subgroup Analysis of Treatment Response to Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years With Attention-Deficit/Hyperactivity Disorder

被引：0
|
作者：
McGough, James J. [1 ,2 ]
Greenbaum, Michael [3 ]
Adeyi, Ben [4 ]
Babcock, Thomas [4 ]
Scheckner, Brian [4 ]
Dirks, Bryan [4 ]
Findling, Robert L. [5 ]
机构：
[1] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[3] Capstone Clin Res, Libertyville, IL USA
[4] Shire Dev Inc, Wayne, PA USA
[5] Univ Hosp Case Med Ctr, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2012年 / 32卷 / 01期
关键词：
CLINICAL-TRIALS; MODERATORS; ADHD;
D O I：
10.1097/JCP.0b013e318240dc53
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：138 / 140
页数：4
相关论文
共 50 条
  • [1] Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder
    Childress, Ann C.
    Findling, Robert L.
    Wu, James
    Kollins, Scott H.
    Wang, Yi
    Martin, Patrick
    Robertson, Brigitte
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2020, 30 (03) : 128 - 136
  • [2] Effect of lisdexamfetamine dimesylate on parent-rated measures in children aged 6 to 12 years with attention-deficit/hyperactivity disorder: A secondary analysis
    Lopez, Frank A.
    Ginsberg, Lawrence D.
    Arnold, Valerie
    POSTGRADUATE MEDICINE, 2008, 120 (03) : 89 - 102
  • [3] Lisdexamfetamine Dimesylate In Attention-Deficit Hyperactivity Disorder in Adults
    Weber, Juliane
    Siddiqui, M. Asif A.
    CNS DRUGS, 2009, 23 (05) : 419 - 425
  • [4] Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents
    Mattos, Paulo
    REVISTA DE PSIQUIATRIA CLINICA, 2014, 41 (02): : 34 - 39
  • [5] An update on lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder
    Wigal, Sharon B.
    Raja, Pooja
    Shukla, Ankita
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (01) : 137 - 145
  • [6] Efficacy and Safety of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder
    Findling, Robert L.
    Childress, Ann C.
    Cutler, Andrew J.
    Gasior, Maria
    Hamdani, Mohamed
    Ferreira-Cornwell, M. Celeste
    Squires, Liza
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2011, 50 (04) : 395 - 405
  • [7] Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder
    Adler, Lenard A.
    Goodman, David
    Weisler, Richard
    Hamdani, Mohamed
    Roth, Thomas
    BEHAVIORAL AND BRAIN FUNCTIONS, 2009, 5
  • [8] Effect Size of Lisdexamfetamine Dimesylate in Adults with Attention-Deficit/Hyperactivity Disorder
    Wigal, Timothy
    Brams, Matthew
    Gasior, Maria
    Gao, Joseph
    Giblin, John
    POSTGRADUATE MEDICINE, 2011, 123 (02) : 169 - 176
  • [9] A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK
    Zimovetz, Evelina A.
    Joseph, Alain
    Ayyagari, Rajeev
    Mauskopf, Josephine A.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2018, 19 (01) : 21 - 35
  • [10] A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK
    Evelina A. Zimovetz
    Alain Joseph
    Rajeev Ayyagari
    Josephine A. Mauskopf
    The European Journal of Health Economics, 2018, 19 : 21 - 35
12345